Fibrin Airway Cast Obstruction: Experience, Classification and Treatment Guideline from Denver

2021 ◽  
Author(s):  
Deborah R. Liptzin ◽  
Matthew D. McGraw ◽  
Paul R. Houin ◽  
Livia A. Veress
Keyword(s):  
Treatment Guideline ◽  
Classification And Treatment

The Classification and Treatment of Headache

1951 ◽  
Vol 35 (5) ◽  
pp. 1485-1493 ◽  
Author(s):  
Madelaine Ray Brown
Keyword(s):  
Classification And Treatment

Factors of Impulsivity and Cluster B Personality Dimensions

2017 ◽  
Vol 38 (4) ◽  
pp. 203-210 ◽  
Author(s):  
Christopher M. Lootens ◽  
Christopher D. Robertson ◽  
John T. Mitchell ◽  
Nathan A. Kimbrel ◽  
Natalie E. Hundt ◽  
...  
Keyword(s):  
Personality Disorders ◽  
The Other ◽  
Diagnostic Classification ◽  
Personality Dimensions ◽  
Cluster B Personality Disorders ◽  
Classification And Treatment

Abstract. The goal of the present investigation was to expand the literature on impulsivity and Cluster B personality disorders (PDs) by conceptualizing impulsivity in a multidimensional manner. Two separate undergraduate samples (n = 223; n = 204) completed measures of impulsivity and Cluster B dimensions. Impulsivity was indeed predictive of Cluster B dimensions and, importantly, each PD scale exhibited a unique impulsivity profile. Findings for borderline PD scores were highly consistent across samples and strongly and positively associated with urgency and lack of perseverance, as expected. Findings for the other PD dimensions also exhibited a fair amount of consistency. Implications of these findings for diagnostic classification and treatment are discussed.

Treatment guideline panel for depression is appointed

2012 ◽  
Author(s):  
Howard Kurtzman ◽  
Lynn Bufka
Keyword(s):  
Treatment Guideline ◽  
Guideline Panel

The Role of Physical Exercise in Obesity and Diabetes

2018 ◽  
Vol 66 (3) ◽  
Keyword(s):  
Type 2 Diabetes ◽  
Type 1 Diabetes ◽  
Glycemic Control ◽  
Physical Exercise ◽  
Treatment Guidelines ◽  
Treatment Guideline ◽  
Obesity And Diabetes ◽  
Regular Physical Exercise

The prevalence of obesity is increasing world-wide. Obesity is associated with a plethora of metabolic and clinical constraints, which result in a higher risk for the development of cardiovascular complications and metabolic disease, particularly insulin resistance and type 2 diabetes. Obesity is an acknowledged determinant of glycemic control in patients with type 1 diabetes and accounts for the majority of premature death due to cardiovascular events. Physical exercise is generally recommended in patients with diabetes in order to prevent the development of or reduce existing obesity, as adopted by every international treatment guideline so far. Regular physical exercise has a beneficial impact on body composition, cardiovascular integrity, insulin sensitivity and quality of life. However, only a minority of patients participates in regular physical exercise, due to individual or ­disease-related barriers. In type 2 diabetes, there is robust evidence for beneficial effects of physical exercise on glycemic control, cardiovascular health and the development of diabetes-related long-term complications. In type 1 diabetes and patients treated with insulin, a higher risk for exercise-­related hypoglycemia has to be considered, which requires certain prerequisites and adequate adaptions of insulin ­dosing. Current treatment guidelines do only incompletely address the development of exercise-related hypoglycemia. However, every patient with diabetes should participate in regular physical exercise in order to support and enable ­sufficient treatment and optimal glycemic control.

MYOCLONIC JERKS AND FALLS“: AETIOLOGY, CLASSIFICATION AND TREATMENT

1968 ◽  
Vol 1 (4) ◽  
pp. 113-120 ◽  
Author(s):  
James W. Lance
Keyword(s):  
Classification And Treatment

scholarly journals Variation in Measures of Antimicrobial Use Across Four Nursing Homes, Atlanta, Georgia, 2019

2020 ◽  
Vol 41 (S1) ◽  
pp. s510-s510
Author(s):  
William Dube ◽  
Sahebi Saiyed ◽  
Patricia Comer ◽  
Michael Hanichen ◽  
Christie Klinczar ◽  
...  
Keyword(s):  
Nursing Homes ◽  
Antibiotic Stewardship ◽  
Respiratory Infections ◽  
Local Treatment ◽  
Treatment Guideline ◽  
Transitions Of Care ◽  
Term Care ◽  
Start Date ◽  
Treatment Site ◽  
Days Of Therapy

Background: Although antibiotic stewardship programs (ASP) are now required in nursing homes, assimilating and responding to data to improve prescribing in nursing homes is novel. Four Atlanta-based skilled nursing facilities (SNFs) began collaborating (EASIL: Emory Antibiotic Stewardship in Long-Term Care) to share standardized prescribing data to allow interfacility comparisons and action. Methods: After SNF ASPs were evaluated and trained, standardized prescribing logs were submitted (January 2019 to June 2019) including the following data: start date, treatment site, prescriber attribution of order (ie, SNF order vs hospital order) and monthly resident days. SNF-specific point estimates of usage rates were calculated as pooled means for all antibiotic starts, SNF-order starts, and days of therapy (DOT), by treatment site per 1,000 resident days. Duration of urinary tract infection (UTI) therapy was assessed by calculating percentage of SNF-UTI starts over recommended duration defined by the local treatment guideline. Rate ratios (RRs) of use were calculated to compare SNF-specific rates to the largest SNF. The 95% CIs were calculated using normal approximation. Results: Monthly starts ranged from 124 to 177, with a pooled mean of 7.8 antibiotic starts (any type), 4.5 SNF-order starts, and 1.2 SNF-UTI starts per 1,000 resident days. Approximately half of all starts were SNF starts (range, 43%–53%), and less than half of DOT were attributed to SNF starts (range, 35%–45%). Overall, SNF-order treatment sites were most often UTIs (29%), lower respiratory infections (17%), and skin and soft-tissue infections (17%). SNF-order UTI starts per 1,000 patient days varied at 1 SNF (SNF B RR, 1.57; 95% CI, 1.04–2.36). SNF-order UTI DOT per 1,000 patient days was more variable, with SNFs B and C having significantly higher rates (B RR, 1.49, 1.24, and 1.82; C RR, 5.42; 95% CI, 4.65–6.34) than SNF A (Fig. 1). The percentage of SNF-order UTI starts that were over recommended duration ranged from 8% (nitrofurantoin, SNF A) to 100% (fluoroquinolones, SNF C) (Fig. 1). Conclusions: Although UTIs are the single most common reason to prescribe antibiotics after arriving in a SNF, they account for a small fraction of overall starts and an even smaller fraction of DOT. We identified outlier prescribing by different SNFs using 3 metrics, suggesting that distinct corrective actions are necessary to target distinct prescribing challenges (starts, duration, and transitions of care).Funding: NoneDisclosures: Scott Fridkin reports that his spouse receives consulting fees from the vaccine industry.

scholarly journals Etiological classification and treatment strategies for secondary bile duct dilatation

2020 ◽  
pp. 153537022096676
Author(s):  
Yunfu Lv ◽  
Ning Liu ◽  
Hongfei Wu ◽  
Zhuori Li
Keyword(s):  
Bile Duct ◽  
Extrahepatic Bile Duct ◽  
Treatment Strategies ◽  
Extensive Literature ◽  
Common Condition ◽  
Endoscopic Dilation ◽  
Biliary Strictures ◽  
Bile Duct Dilatation ◽  
Duct Dilatation ◽  
Classification And Treatment

Secondary intra- and extrahepatic bile duct dilatation is a very common condition that can be caused by several diseases. However, it has been rarely discussed in the specialized literature. Moreover, no distinct etiology can be determined in some cases, which hampers the diagnosis and treatment. Here, we discuss the etiological classification and treatment strategies of secondary intra- and extrahepatic bile duct dilatation based on an extensive literature review, as well as our experimental research and clinical experience. The etiology of secondary intra- and extrahepatic bile duct dilatation can be classified in different ways. From a clinicopathological perspective, it can be classified into obstruction-, lesion-, and compression-induced dilatation. Treatment varies depending on the cause. For example, endoscopic dilation or stenting is used for biliary strictures, laparoscopic choledochectomy for stone removal, and resection for cholangiocarcinoma.

Sign in / Sign up

Export Citation Format

Share Document